Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

Table 2 Characteristics of bone metabolism in patients with chronic viral liver disease.

Parameter	All patients (n = 43)	Hepatitis B (n = 13)	Hepatitis C (n = 30)
AlkPhos (mmol/L s)	2.95 (1.32–10.87)	2.39 (1.96–6.67)	2.98 (1.32–10.87)
BALP (mmol/L s)	1.69 (0.76–3.89)	1.52 (0.76–2.94)	1.51 (0.76–3.89)
iPTH (pmol/L)	2.57 (1.35–5.96)	2.59 (1.35–5.96)	2.69 (1.45–5.38)
25 (OH)D3 (pg/mL)	27.4 (11.9–65.7)	27.40 (15.40–60.20)	28.05 (11.90–65.70)
1,25 (OH)2D3 (pg/mL)	38.7 (10.0–86.8)	41.40 (21.50–60.7)	38.20 (10.00–86.80)
Phosphate (mmol/L)	1.08 (0.57–1.43)	0.95 (0.57–1.15)	1.09 (0.67–1.43)
Ca (mmol/L)	2.43 (2.17–2.58)	2.44 (2.22–2.58)	2.39 (2.17–2.57)
iCa (mmol/L)	1.23 (0.99–1.34)	1.22 (1.12–1.29)	1.25 (0.99–1.34)
PD/UCr (pmol/µmoL)	58.0 (30.0–235.0)	59.0 (30.0–102.0)	57.00 (34.00–235.00)
DPD/UCr (pmol/mmoL)	13.3 (6.3–50.5)	10.6 (6.3–26.7)	13.85 (6.4–50.5)